Andrew D J Pearson, Nicole Scobie, Koenraad Norga, Franca Ligas, Davy Chiodin, Amos Burke, Veronique Minard-Colin, Peter Adamson, Lynley V Marshall, Arun Balakumaran, Bouchra Benettaib, Pankaj Bhargava, Catherine M Bollard, Ellen Bolotin, Simon Bomken, Jochen Buechner, Birgit Burkhardt, Hubert Caron, Christopher Copland, Pierre Demolis, Anton Egorov, Mahdi Farhan, Gerhard Zugmaier, Thomas Gross, Danielle Horton-Taylor, Wolfram Klapper, Giovanni Lesa, Robert Marcus, Rodney R Miles, Kerri Nottage, Lida Pacaud, Rosanna Ricafort, Martin Schrappe, Jaroslav Sterba, Remus Vezan, Susan Weiner, Su Young Kim, Gregory Reaman, Gilles Vassal
Paediatric Strategy Forums have been created by the multistakeholder organisation, ACCELERATE, and the European Medicines Agency to facilitate dialogue between all relevant stakeholders and suggest strategies in critical areas of paediatric oncology drug development. As there are many medicines being developed for B-cell malignancies in adults but comparatively few in children with these malignancies, a Paediatric Strategy Forum was held to discuss the best approach to develop these products for children. It was concluded that as current frontline therapy is highly successful, despite associated acute toxicity, de-escalation of this or substitution of presently used drugs with new medicines can only be undertaken when there is an effective salvage regimen, which is currently not available...
February 14, 2019: European Journal of Cancer